Latest News & Features
Americas
Generic makers Teva, Mylan and Akorn asked the US Court of Appeals for the Federal Circuit not to stay to its sovereign immunity ruling pending an appeal by Allergan and the Saint Regis Mohawk Tribe to the US Supreme Court. 7 November 2018
Americas
Pfizer has entered into an oncology collaboration with Nektar Therapeutics, a US development stage biopharma company. 7 November 2018
Big Pharma
Germany’s Federal Patent Court has published the reasoning behind its decision to revoke Gilead Sciences’ supplementary protection certificate for HIV/AIDS treatment Truvada, 6 November 2018
Americas
Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report. 6 November 2018
Big Pharma
HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner. 5 November 2018
Americas
A US district court has ordered Australia-based Cochlear to pay $268 million in damages to the Alfred E Mann Foundation for Scientific Research and Advanced Bionics. 5 November 2018
Americas
Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion. 2 November 2018
Americas
California-based Gilead Sciences has signed a collaboration agreement with Tango Therapeutics to discover and develop a pipeline of immuno-oncology treatments for cancer patients. 2 November 2018
Americas
Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft. 1 November 2018
Europe
The company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, ERS Genomics, has signed a patent licensing deal with DefiniGEN, a spin-out from the University of Cambridge, UK. 1 November 2018